Dynamic contrast-enhanced breast MR imaging was performed on 14 patients (five cancerous lesions, nine benign) with sliceselective spoiled gradient-recalled echo (2D SPGR) imaging. Adiabatic saturation recovery T 1 measurements were performed before (T 1pre ) and after (T 1post ) 2D SPGR imaging. These two "bookend" T 1 measurements were used to calibrate the equations which were employed to convert the time course of the 2D SPGR signal strength to T 1 -vs.-time, which in turn was used to compute the gadolinium concentration-vs.-time ([C](t)) in the lesion. The extraction-flow product (EF) was computed for each lesion by pharmacokinetic modeling of [C](t). For this study, EF provided a sensitivity and specificity for cancer of 100% and 78%, respectively. When only T 1pre was used to estimate [C](t) (which assumes a priori knowledge of the shape and amplitude of the slice profile), the sensitivity and specificity fell to 80% and 56%, respectively. This is presumably due to unexpected variations in the shape and/or amplitude of the slice profile, which could be caused by factors such as patient-to-patient variations in breast geometry or inconsistently set transmit gains. Therefore, both T 1pre and T 1post measurements are necessary for optimum sensitivity and specificity using pharmacokinetic analysis.
Quantitative T 1 -weighted dynamic contrast-enhanced MRI (T 1 -w DCE-MRI) is used by many researchers for detecting and evaluating breast disease (1) (2) (3) (4) (5) (6) . This technique involves intravenous injection of a gadolinium (Gd) contrast agent during rapid (ϳsec), repeated T 1 -weighted imaging. From these images, the Gd concentration-vs.-time ([C](t)) of a lesion of interest can be estimated (1) (2) (3) (4) 6, 7) . Pharmacokinetic modeling can then be applied to [C] (t) to extract parameters such as the extraction-flow product (EF, which is equivalent to K trans ) (1, 4, 5, 8) . These parameters are useful for lesion diagnosis and tracking of treatment progress.
A broad class of pulse sequences frequently used for T 1 -w DCE-MRI is slice-selective (i.e., two-dimensional) spoiled gradient-recalled echo (2D SPGR) imaging (2, 3, 6, 7, 9, 10) . Such pulse sequences are often used for T 1 -w DCE-MRI because they provide relatively artifact-free images with the high temporal resolution (Ͻϳ15 sec), which is useful for differentiating benign from malignant breast lesions (11) .
The signal-vs.-time (S(t)) of a pixel or region of interest (ROI) in a lesion can be measured directly from the 2D SPGR images. The goal is then to convert S(t) to T 1 (t), which can subsequently be used to compute [C](t) for pharmacokinetic modeling (1, 4, 9, 12) . The T 1 (t) can be estimated from S(t) by utilizing a 2D SPGR signal strength equation which gives the relationship between S and T 1 . The signal strength equation has an overall scaling factor which must be determined either by measuring T 1 before injection of the Gd contrast agent (T 1pre ) or by measuring one or more values of S obtained with special flip angles and TR settings (4, 6, 7, 9, 13) .
Unfortunately, the 2D SPGR signal strength is very sensitive to even modest variations in the transmit magnetic field (B 1 ), which can cause the signal strength equation to become more and more inaccurate as the T 1 shortens (and [C] increases) postinjection (7) . This can lead to significant errors (Ͼ50%) in the estimated [C](t) (7) . Inaccuracies in [C](t) are undesirable because they lead to errors in the estimated pharmacokinetic parameters, reducing sensitivity and specificity and making the method less consistent for tracking treatment progress.
We have demonstrated that a second measurement of T 1 (denoted T 1post ), performed after the dynamic contrastenhanced 2D SPGR imaging, can minimize the errors in the estimated T 1 (t) (7) . This second T 1 measurement is an important part of the "Bookend Method" that we have developed, which allows T 1 (t) to be estimated accurately (Ͻϳ10% error) from 2D SPGR image data, even in the presence of variations in B 1 or the slice-select profile shape (7) . For the Bookend Method, T 1pre and T 1post are employed to calibrate and correct the 2D SPGR signal strength equation used to estimate T 1 (t).
The purpose of this work was to validate the clinical usefulness of the Bookend Method for quantitative T 1 -w DCE-MRI of the breast. In order to do this, it was first necessary to develop a reasonably fast (ϳmin) clinical T 1 measurement imaging pulse sequence which would be insensitive to variations in B 1 . The Bookend Method was then performed on a group of 14 patients (five cancerous lesions, nine benign lesions). For each lesion, EF was calculated from the estimated [C](t) data and compared to pathological diagnosis. In order to compare the Bookend Method with a more conventional approach of estimating [C](t), the entire analysis was repeated using T 1pre but ignoring T 1post .
MATERIALS AND METHODS
This study was approved by the Kingston General Hospital and Ottawa Hospital Human Research Ethics Boards. Fourteen patients with either palpable lumps or mammographically or sonographically suspicious lesions were recruited who were scheduled for surgical biopsy. Informed written consent was obtained from each patient prior to each MR imaging exam. Imaging was performed with 1.5 T Signa Imaging Systems (General Electric, Milwaukee, WI) and a transmit/receive breast coil (MRI Devices, Milwaukee, WI).
For each patient, the lesion was first localized with conventional MRI pulse sequences (20) . Subsequently, the following protocol was used: Postprocessing was performed off-line with Matlab (MathWorks, Natick MA). For each 2D SPGR imaging slice which contained part of the lesion, an ROI was manually drawn on the area of the lesion which demonstrated the greatest signal enhancement, defined as ⌬S ϭ S(tϭ2 min) -S(tϭ0 min). Each ROI covered a group of contiguous pixels for which ⌬S was at least 80% of the maximum ⌬S for that slice.
Each ROI was propagated through the saturation recovery and 2D SPGR images. T 1pre and T 1post were each determined with a three-parameter fit to the four recovery points. For each ROI, T 1 (t) was estimated from S(t) using the Bookend Method analysis (Method 4 in Ref. 7) . For this analysis, T 1pre and T 1post were used to correct a lookup table that relates S and T 1 (7) . The change in 1/T 1 as a function of time was converted to [C](t) by dividing by 4.5 mM -1 s -1 (12) . The conversion of T 1 (t) to [C](t) assumed that the intravascular component was insignificant and that there was slow exchange of water between the plasma and the extravascular space (14) . Under these assumptions, [C](t) represents the time course of the average concentration of Gd in the extravascular space (14) .
The [C](t) data were fit to a well-known pharmacokinetic model:
ͬ .
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For this equation, C a (t) is the arterial input function (AIF), defined as the concentration-vs.-time of Gd in the plasma of the arterial blood supply. For this study, C a (t) was not measured for each patient. Instead, an approximate average of published data was used (15, 16) . The peak amplitude (2.7 mM) of the initial bolus phase (t ϭ 0 to ϳ25 s) of this average AIF was calculated by averaging the peak amplitudes of the six AIF measurements shown in fig. 8 of Fritz-Hansen et al. (15) . The initial, rapid washout of the average AIF from that peak value (t ϭ ϳ25 to 50 sec) was modeled as a simple monoexponential decay with no recirculation. The rate constant for this decay (0.12 s -1 ) was calculated by fitting a monoexponential decay to the initial washout phase of each of the Fritz-Hansen curves, then averaging the resultant rate constants. The longer, slower washout phase of the average AIF (t ϭ ϳ50 -600 sec) was calculated similarly from data published by Weinmann et al. (16) .
The unitless quantity , a free-floating parameter for the curve fit of Eq. 1, is the volume fraction of extravascular space occupied by the extracellular interstitial space (i.e., the space outside the cells and capillaries). The term EF (the other free-floating parameter) is known as the extraction-flow product. EF was expressed in units of ml/(min 100 g), under the assumption of unit density of tissue, to facilitate comparison to other studies (4, 5, 8) . To further facilitate such comparison, the value of EF extracted from the curve fit was subsequently divided by one minus the hematocrit (Hc ϭ 40% assumed). This adjustment made the EF values more consistent with those of many other investigators who use whole blood concentrations for C a (t) instead of plasma concentrations (4).
For each lesion, a set of EF values was therefore obtained which corresponded to the set of ROIs which had been drawn. The maximum EF value in that set was defined as the one which was representative of the lesion. As a comparison, the entire analysis was repeated using the ROI which corresponded to that maximum EF value, this time assuming that there were no imperfections in the 2D SPGR signal strength equation (e.g., no variations in B 1 or slice profile shape). Under this assumption, [C](t) could be estimated accurately using only the T 1pre measurement (4, 7, 13) . This alternative analysis method is known as the "Single-T 1pre Method" (Method 2 in Ref. 7) , in contrast to the Bookend Method, which utilizes both T 1pre and T 1post .
The T 1pre and T 1post measurements were obtained with an ASR pulse sequence. For the acquisition of each line of k-space, a nonselective sin/cos adiabatic saturation pulse was applied, followed by a recovery time , followed by readout pulses and data acquisition for all slices (17) . An adiabatic saturation pulse was used in order to make the T 1 measurement less sensitive to B 1 inhomogeneities. The nonselective sin/cos pulse was applied for 102 ms. This pulse started 233 Hz off-resonance and ended with a maximum B 1 amplitude of ϳ0.073 Gauss. The pulse sequence had conventional, sequential phase encode ordering and interleaved slice ordering. Thus, after the recovery time , slices 1, 3, 5, then 7 were read out, followed immediately by slices 2, 4, 6, then 8. The pulse sequence was repeated with the same until an entire image had been acquired. One image was acquired for each of four values of as described above.
The peak specific absorption rate (SAR) generated in the breast by the ASR pulse sequence was calculated to be under 8 W/kg, which is the limit recommended by the United States Food and Drug Administration for a local transmitter coil. This calculation was done using manufacturer-supplied information and was based on the assumption that the transmit/receive breast coil and the transmit/receive head coil behave similarly in terms of RF heating.
Numerical simulations were performed in order to determine the theoretical accuracy of this ASR T 1 measurement technique. T 1 was fit to simulated, noiseless, recovery data for values of 230, 470, 877, and 3000 ms. Recovery data were generated for all combinations of the following parameters: T 1 (400, 1200 ms); T 2 (50, 300 ms); B 1 inhomogeneity (i.e., the actual B 1 divided by the expected B 1 ) (0.5, 0.75, 1.0, 1.25, 2.0); and resonant offset (-25, 0, 25 Hz). For each case of T 1 , T 2 , B 1 inhomogeneity, and resonant offset, the effect of the adiabatic pulse was calculated by solving the Bloch equations numerically. The readout pulses were assumed to be single-lobed sinc pulses which are typically used in 2D SPGR imaging.
Phantom experiments were also performed to test the accuracy of the ASR technique: 12 mm-and 5 mm-wide plastic tube phantoms were filled with different aqueous concentrations of Gd contrast agent providing T 1 ranging from 1290 Ϯ 10 ms down to 450 Ϯ 5 ms as measured by inversion recovery (IR). This range of T 1 was used because it is approximately the range expected in vivo. The IR measurements were performed with a single-slice IR technique with 12 inversion time (TI) values ranging from 50 -8000 ms, and TR ϭ TI ϩ 9000 ms. For this work, the IR measurements were considered the "Gold Standard" measurements of T 1 .
For ASR imaging, the tubes were placed upright at 8 to 9 different positions in a 9-cm high plastic container of water. The transmit/receive breast coil was used to obtain coronal images of this container with a slice thickness of 5 mm, 8 contiguous slices, matrix ϭ 256 ϫ 128, and field of view ϭ 16 cm. T 1 measurements with ASR were repeated six times for different locations in the water container and different arrangements of the phantom tubes. A total of 816 ASR T 1 measurements were performed, covering a volume of 830 cm 3 , which is nearly all the useful imaging volume of the coil. values of 230, 635, 1329, and 2920 ms were used to measure the T 1 of the tubes with T 1 Ͼ 650 ms, while values of 230, 432, 775, and 2920 ms were used to measure the T 1 of the tubes with T 1 Ͻ 650 ms. These sampling schemes were the same as those which were used for the patients to measure T 1pre (which was expected to be Ͼ650 ms) and T 1post (which was expected to be Ͻ650 ms).
RESULTS
For the simulations, the ASR technique maintained reasonably small errors (Ͻ10%) even down to B 1 inhomogeneities of 0.5. In phantoms, the ASR technique measured T 1 accurately (5%) for all experiments. Figure 1 shows representative ASR and 2D SPGR images. Figure 2 shows the correction that had to be applied to the 2D SPGR signal strength equation for the Bookend Method, as a function of 1/T 1 for all 14 patients. The ordinate may also be described as the ratio of the actual 2D SPGR signal strength to the theoretical value predicted by the signal strength equation. Although this ratio is linear with T 1 (7), the plot was displayed as a function of 1/T 1 to give a sense of how it can vary wildly from patient to patient with increasing Gd concentration. This figure shows that the actual 2D SPGR signal strength may differ from the theoretical value by factors ranging from ϳ0.8 -1.5 and underlines the value of the second T 1 bookend measurement (T 1post ). Figure 3 shows example tissue [C](t) data for two lesions from two different patients. One of the lesions was benign (proliferative dysplasia) and the other was cancerous (infiltrating moderately differentiated ductal carcinoma). Both lesions were ϳ5 mm in size. Figure 3a Figure 3a gives the false impression that the benign lesion absorbed a higher concentration of Gd than the cancerous lesion. In fact, as shown in Fig. 3b , the cancerous lesion had a much more aggressive enhancement than the benign lesion. Figure 4 shows EF values for all the lesions for (4a) the Single-T 1pre Method and (4b) the Bookend Method. For each of the two methods, an EF threshold between cancerous and benign lesions was chosen which would maximize sensitivity and specificity. For the Single-T 1pre Method, the sensitivity and specificity were 80% and 56%, respectively. For the Bookend Method, the sensitivity and specificity were 100% and 78%, respectively.
For the Bookend Method analysis, the average value of was found to be 0.59 Ϯ 0.31 for malignant lesions and 0.70 Ϯ 0.26 for benign lesions. The average uncertainty in the curve fits for EF was 7% (range 1-10%), whereas that for was 6% (range 1-15%). The average measured value of T 1pre was 1256 Ϯ 142 ms for the cancerous lesions and 1537 Ϯ 265 ms for the benign lesions. For T 1post , these numbers were 446 Ϯ 151 ms and 508 Ϯ 148 ms, respectively.
DISCUSSION
The results of this study show that a single preinjection T 1 measurement is not sufficient for estimating [C](t) reliably from rapid 2D SPGR imaging for pharmacokinetic modeling. This is because the discrepancy between the measured 2D SPGR signal strength and its theoretical value is not consistent from lesion to lesion (Fig. 2) . This inconsistency is presumably due to unexpected variations in the B 1 or slice-select profile, which could be caused by factors such as patient-to-patient variations in breast geometry or inconsistently set transmit gains. The Bookend Method, however, circumvents these problems by obtaining a caseby-case empirical calibration of 2D SPGR signal strength vs. T 1 . The [C](t) as estimated by the Bookend Method should therefore be much more accurate than [C](t) estimated by the Single-T 1pre Method. This is consistent with the fact that the Bookend Method provided higher sensitivity and specificity for this study than the Single-T 1pre Method, given the assumption that there should be a significant separation in EF values between cancerous and benign lesions.
For the Bookend Method, it is important that the accuracy of the T 1pre and T 1post measurements not be adversely affected by the same variations in the B 1 or slice-select profile which render the Single-T 1pre Method unreliable. For this reason, we chose a T 1 measurement method (ASR) which would be relatively unaffected by B 1 inhomogeneities. The ASR method demonstrated low systematic errors (Ͻ5%) for both the simulations and phantom experiments.
The principal drawback of the Bookend Method is that the exam time must be lengthened to accommodate the T 1post measurement. If limiting the total exam time is crucial, both bookend T 1 measurements could be performed with a faster, more efficient method such as one of the Look-Locker techniques (18) . Whatever fast T 1 measurement method is chosen, it must maintain the same spatial resolution as the 2D SPGR imaging and not suffer problems from B 1 inhomogeneities or multislice interference.
One of the weaknesses of this study, and most other studies which have been published on breast MR, is the lack of a true arterial input function (19) . The assumed input function used was based on the approximate average of some input function data obtained from a small group of subjects (15, 16) . However, changes in the input function from one individual to another could cause significant changes in the [C](t) data, leading to unwanted variations in the measured pharmacokinetic parameters (19) . Based on the work by Port et al. (fig. 7 of Ref. 19) , it can be estimated that using the same input function for all patients will cause unwanted errors in the pharmacokinetic parameters of about 25% on average. However, a certain fraction of patients (ϳ15% in Port et al.) will have input functions which deviate very significantly from the average, leading to very large (Ͼ40%) errors. Therefore, there is a need to develop rapid, accurate methods for measuring the arterial input function while simultaneously acquiring the Gd concentration-vs.-time in the breast tissue ([C](t)).
CONCLUSIONS
For dynamic contrast-enhanced MR imaging of the breast, when estimating [C](t) for a lesion from T 1 -weighted 2D SPGR imaging, it is not sufficient to use a single preinjection T 1 measurement (T 1pre ) to calibrate the signal strength equations used to convert signal strength to T 1 . This is because the discrepancy between the measured signal strength and its theoretical value is not consistent from lesion to lesion. A second T 1 measurement, performed after the dynamic contrast-enhanced imaging (T 1post ), must be done to obtain a case-by-case empirical calibration of signal strength vs. T 1 . This improves the accuracy of the estimated [C](t) and ultimately improves sensitivity and specificity for the pharmacokinetic parameter(s) used to differentiate benign from malignant tumors (e.g., the extraction-flow product which was used in this work). For this particular patient study (n ϭ 14), using the two T 1 measurements (the "Bookend Method"), gave a sensitivity and specificity of 100% and 78%, respectively, compared to use of the preinjection T 1 measurement alone, which had a poorer performance (80% and 56%, respectively). The power of the Bookend Method is that, as long as T 1pre and T 1post are measured accurately, [C](t) can be estimated reliably from 2D SPGR signal strengths without any a priori knowledge of system imperfections.
